http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 02 Jun 2026 16:14:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ACHIEVE+LIFE+SCIENCES%2C++++For%3A+May+29++Filed+by%3A+Waldman+Reid+Alexander/26591805.html si-local-file:///var/storage/secattach/20260602/26591805.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ACHIEVE+LIFE+SCIENCES%2C++++For%3A+May+29++Filed+by%3A+Waldman+Reid+Alexander/26591805.html Tue, 02 Jun 2026 16:14:00 -0400 ACHV O.00644671 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ACHIEVE+LIFE+SCIENCES%2C++++For%3A+May+29++Filed+by%3A+Waldman+Reid+Alexander/26591805.html si-local-file:///var/storage/secattach/20260602/26591805.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ACHIEVE+LIFE+SCIENCES%2C++++For%3A+May+29++Filed+by%3A+Waldman+Reid+Alexander/26591805.html Tue, 02 Jun 2026 16:14:00 -0400 ACHV O.00644671 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ACHIEVE+LIFE+SCIENCES%2C++++For%3A+May+29++Filed+by%3A+Farrow+Jeffrey+S/26591783.html si-local-file:///var/storage/secattach/20260602/26591783.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ACHIEVE+LIFE+SCIENCES%2C++++For%3A+May+29++Filed+by%3A+Farrow+Jeffrey+S/26591783.html Tue, 02 Jun 2026 16:12:00 -0400 ACHV O.00644671 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ACHIEVE+LIFE+SCIENCES%2C++++For%3A+May+29++Filed+by%3A+Farrow+Jeffrey+S/26591783.html si-local-file:///var/storage/secattach/20260602/26591783.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ACHIEVE+LIFE+SCIENCES%2C++++For%3A+May+29++Filed+by%3A+Farrow+Jeffrey+S/26591783.html Tue, 02 Jun 2026 16:12:00 -0400 ACHV O.00644671 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ACHIEVE+LIFE+SCIENCES%2C++++For%3A+May+29++Filed+by%3A+Farrow+Jeffrey+S/26591739.html si-local-file:///var/storage/secattach/20260602/26591739.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ACHIEVE+LIFE+SCIENCES%2C++++For%3A+May+29++Filed+by%3A+Farrow+Jeffrey+S/26591739.html Tue, 02 Jun 2026 16:11:00 -0400 ACHV O.00644671 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ACHIEVE+LIFE+SCIENCES%2C++++For%3A+May+29++Filed+by%3A+Farrow+Jeffrey+S/26591739.html si-local-file:///var/storage/secattach/20260602/26591739.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ACHIEVE+LIFE+SCIENCES%2C++++For%3A+May+29++Filed+by%3A+Farrow+Jeffrey+S/26591739.html Tue, 02 Jun 2026 16:11:00 -0400 ACHV O.00644671 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ACHIEVE+LIFE+SCIENCES%2C++++For%3A+May+29++Filed+by%3A+Waldman+Reid+Alexander/26591753.html si-local-file:///var/storage/secattach/20260602/26591753.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ACHIEVE+LIFE+SCIENCES%2C++++For%3A+May+29++Filed+by%3A+Waldman+Reid+Alexander/26591753.html Tue, 02 Jun 2026 16:11:00 -0400 ACHV O.00644671 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ACHIEVE+LIFE+SCIENCES%2C++++For%3A+May+29++Filed+by%3A+Waldman+Reid+Alexander/26591753.html si-local-file:///var/storage/secattach/20260602/26591753.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ACHIEVE+LIFE+SCIENCES%2C++++For%3A+May+29++Filed+by%3A+Waldman+Reid+Alexander/26591753.html Tue, 02 Jun 2026 16:11:00 -0400 ACHV O.00644671 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ACHIEVE+LIFE+SCIENCES%2C++++For%3A+May+29/26588353.html si-local-file:///var/storage/secattach/20260602/26588353.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ACHIEVE+LIFE+SCIENCES%2C++++For%3A+May+29/26588353.html Tue, 02 Jun 2026 08:52:00 -0400 ACHV O.00644671 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ACHIEVE+LIFE+SCIENCES%2C++++For%3A+May+29/26588353.html si-local-file:///var/storage/secattach/20260602/26588353.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ACHIEVE+LIFE+SCIENCES%2C++++For%3A+May+29/26588353.html Tue, 02 Jun 2026 08:52:00 -0400 ACHV O.00644671 http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html <p>Achieve Life Sciences Inc. (NASDAQ: ACHV) appointed Jeffrey Farrow and Reid Waldman to its board of directors as the company prepares to resubmit its new drug application for cytisinicline, a smoking cessation treatment.</p> <p>Farrow serves as chief financial officer and chief strategy officer at Tarsus Pharmaceuticals Inc. (NASDAQ: TARS), where he has overseen the commercial launch of XDEMVY for Demodex blepharitis. He previously held CFO positions at three companies that were acquired for more than $9 billion combined, including Global Blood Therapeutics, which Pfizer acquired for approximately $5.4 billion in December 2022.</p> <p>Waldman is founder and CEO of Veradermics Inc. (NYSE: MANE), http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html Tue, 02 Jun 2026 08:31:08 -0400 A.14610943 A.21388897 A.26756439 A.50113906 ACHV MANE O.00644671 O.13716952 O.45210133 O.48400419 O.48989253 O.53486143 TARS http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html <p>Achieve Life Sciences Inc. (NASDAQ: ACHV) appointed Jeffrey Farrow and Reid Waldman to its board of directors as the company prepares to resubmit its new drug application for cytisinicline, a smoking cessation treatment.</p> <p>Farrow serves as chief financial officer and chief strategy officer at Tarsus Pharmaceuticals Inc. (NASDAQ: TARS), where he has overseen the commercial launch of XDEMVY for Demodex blepharitis. He previously held CFO positions at three companies that were acquired for more than $9 billion combined, including Global Blood Therapeutics, which Pfizer acquired for approximately $5.4 billion in December 2022.</p> <p>Waldman is founder and CEO of Veradermics Inc. (NYSE: MANE), http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html Tue, 02 Jun 2026 08:31:08 -0400 A.14610943 A.21388897 A.26756439 A.50113906 ACHV MANE O.00644671 O.13716952 O.45210133 O.48400419 O.48989253 O.53486143 TARS http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html <p>Achieve Life Sciences Inc. (NASDAQ: ACHV) appointed Jeffrey Farrow and Reid Waldman to its board of directors as the company prepares to resubmit its new drug application for cytisinicline, a smoking cessation treatment.</p> <p>Farrow serves as chief financial officer and chief strategy officer at Tarsus Pharmaceuticals Inc. (NASDAQ: TARS), where he has overseen the commercial launch of XDEMVY for Demodex blepharitis. He previously held CFO positions at three companies that were acquired for more than $9 billion combined, including Global Blood Therapeutics, which Pfizer acquired for approximately $5.4 billion in December 2022.</p> <p>Waldman is founder and CEO of Veradermics Inc. (NYSE: MANE), http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html Tue, 02 Jun 2026 08:31:08 -0400 A.14610943 A.21388897 A.26756439 A.50113906 ACHV MANE O.00644671 O.13716952 O.45210133 O.48400419 O.48989253 O.53486143 TARS http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html <p>Achieve Life Sciences Inc. (NASDAQ: ACHV) appointed Jeffrey Farrow and Reid Waldman to its board of directors as the company prepares to resubmit its new drug application for cytisinicline, a smoking cessation treatment.</p> <p>Farrow serves as chief financial officer and chief strategy officer at Tarsus Pharmaceuticals Inc. (NASDAQ: TARS), where he has overseen the commercial launch of XDEMVY for Demodex blepharitis. He previously held CFO positions at three companies that were acquired for more than $9 billion combined, including Global Blood Therapeutics, which Pfizer acquired for approximately $5.4 billion in December 2022.</p> <p>Waldman is founder and CEO of Veradermics Inc. (NYSE: MANE), http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html Tue, 02 Jun 2026 08:31:08 -0400 A.14610943 A.21388897 A.26756439 A.50113906 ACHV MANE O.00644671 O.13716952 O.45210133 O.48400419 O.48989253 O.53486143 TARS http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html <p>Achieve Life Sciences Inc. (NASDAQ: ACHV) appointed Jeffrey Farrow and Reid Waldman to its board of directors as the company prepares to resubmit its new drug application for cytisinicline, a smoking cessation treatment.</p> <p>Farrow serves as chief financial officer and chief strategy officer at Tarsus Pharmaceuticals Inc. (NASDAQ: TARS), where he has overseen the commercial launch of XDEMVY for Demodex blepharitis. He previously held CFO positions at three companies that were acquired for more than $9 billion combined, including Global Blood Therapeutics, which Pfizer acquired for approximately $5.4 billion in December 2022.</p> <p>Waldman is founder and CEO of Veradermics Inc. (NYSE: MANE), http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html Tue, 02 Jun 2026 08:31:08 -0400 A.14610943 A.21388897 A.26756439 A.50113906 ACHV MANE O.00644671 O.13716952 O.45210133 O.48400419 O.48989253 O.53486143 TARS http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html <p>Achieve Life Sciences Inc. (NASDAQ: ACHV) appointed Jeffrey Farrow and Reid Waldman to its board of directors as the company prepares to resubmit its new drug application for cytisinicline, a smoking cessation treatment.</p> <p>Farrow serves as chief financial officer and chief strategy officer at Tarsus Pharmaceuticals Inc. (NASDAQ: TARS), where he has overseen the commercial launch of XDEMVY for Demodex blepharitis. He previously held CFO positions at three companies that were acquired for more than $9 billion combined, including Global Blood Therapeutics, which Pfizer acquired for approximately $5.4 billion in December 2022.</p> <p>Waldman is founder and CEO of Veradermics Inc. (NYSE: MANE), http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html Tue, 02 Jun 2026 08:31:08 -0400 A.14610943 A.21388897 A.26756439 A.50113906 ACHV MANE O.00644671 O.13716952 O.45210133 O.48400419 O.48989253 O.53486143 TARS http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html <p>Achieve Life Sciences Inc. (NASDAQ: ACHV) appointed Jeffrey Farrow and Reid Waldman to its board of directors as the company prepares to resubmit its new drug application for cytisinicline, a smoking cessation treatment.</p> <p>Farrow serves as chief financial officer and chief strategy officer at Tarsus Pharmaceuticals Inc. (NASDAQ: TARS), where he has overseen the commercial launch of XDEMVY for Demodex blepharitis. He previously held CFO positions at three companies that were acquired for more than $9 billion combined, including Global Blood Therapeutics, which Pfizer acquired for approximately $5.4 billion in December 2022.</p> <p>Waldman is founder and CEO of Veradermics Inc. (NYSE: MANE), http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html Tue, 02 Jun 2026 08:31:08 -0400 A.14610943 A.21388897 A.26756439 A.50113906 ACHV MANE O.00644671 O.13716952 O.45210133 O.48400419 O.48989253 O.53486143 TARS http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html <p>Achieve Life Sciences Inc. (NASDAQ: ACHV) appointed Jeffrey Farrow and Reid Waldman to its board of directors as the company prepares to resubmit its new drug application for cytisinicline, a smoking cessation treatment.</p> <p>Farrow serves as chief financial officer and chief strategy officer at Tarsus Pharmaceuticals Inc. (NASDAQ: TARS), where he has overseen the commercial launch of XDEMVY for Demodex blepharitis. He previously held CFO positions at three companies that were acquired for more than $9 billion combined, including Global Blood Therapeutics, which Pfizer acquired for approximately $5.4 billion in December 2022.</p> <p>Waldman is founder and CEO of Veradermics Inc. (NYSE: MANE), http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html Tue, 02 Jun 2026 08:31:08 -0400 A.14610943 A.21388897 A.26756439 A.50113906 ACHV MANE O.00644671 O.13716952 O.45210133 O.48400419 O.48989253 O.53486143 TARS http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html <p>Achieve Life Sciences Inc. (NASDAQ: ACHV) appointed Jeffrey Farrow and Reid Waldman to its board of directors as the company prepares to resubmit its new drug application for cytisinicline, a smoking cessation treatment.</p> <p>Farrow serves as chief financial officer and chief strategy officer at Tarsus Pharmaceuticals Inc. (NASDAQ: TARS), where he has overseen the commercial launch of XDEMVY for Demodex blepharitis. He previously held CFO positions at three companies that were acquired for more than $9 billion combined, including Global Blood Therapeutics, which Pfizer acquired for approximately $5.4 billion in December 2022.</p> <p>Waldman is founder and CEO of Veradermics Inc. (NYSE: MANE), http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html Tue, 02 Jun 2026 08:31:08 -0400 A.14610943 A.21388897 A.26756439 A.50113906 ACHV MANE O.00644671 O.13716952 O.45210133 O.48400419 O.48989253 O.53486143 TARS http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html <p>Achieve Life Sciences Inc. (NASDAQ: ACHV) appointed Jeffrey Farrow and Reid Waldman to its board of directors as the company prepares to resubmit its new drug application for cytisinicline, a smoking cessation treatment.</p> <p>Farrow serves as chief financial officer and chief strategy officer at Tarsus Pharmaceuticals Inc. (NASDAQ: TARS), where he has overseen the commercial launch of XDEMVY for Demodex blepharitis. He previously held CFO positions at three companies that were acquired for more than $9 billion combined, including Global Blood Therapeutics, which Pfizer acquired for approximately $5.4 billion in December 2022.</p> <p>Waldman is founder and CEO of Veradermics Inc. (NYSE: MANE), http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html Tue, 02 Jun 2026 08:31:08 -0400 A.14610943 A.21388897 A.26756439 A.50113906 ACHV MANE O.00644671 O.13716952 O.45210133 O.48400419 O.48989253 O.53486143 TARS http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html <p>Achieve Life Sciences Inc. (NASDAQ: ACHV) appointed Jeffrey Farrow and Reid Waldman to its board of directors as the company prepares to resubmit its new drug application for cytisinicline, a smoking cessation treatment.</p> <p>Farrow serves as chief financial officer and chief strategy officer at Tarsus Pharmaceuticals Inc. (NASDAQ: TARS), where he has overseen the commercial launch of XDEMVY for Demodex blepharitis. He previously held CFO positions at three companies that were acquired for more than $9 billion combined, including Global Blood Therapeutics, which Pfizer acquired for approximately $5.4 billion in December 2022.</p> <p>Waldman is founder and CEO of Veradermics Inc. (NYSE: MANE), http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html Tue, 02 Jun 2026 08:31:08 -0400 A.14610943 A.21388897 A.26756439 A.50113906 ACHV MANE O.00644671 O.13716952 O.45210133 O.48400419 O.48989253 O.53486143 TARS http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html <p>Achieve Life Sciences Inc. (NASDAQ: ACHV) appointed Jeffrey Farrow and Reid Waldman to its board of directors as the company prepares to resubmit its new drug application for cytisinicline, a smoking cessation treatment.</p> <p>Farrow serves as chief financial officer and chief strategy officer at Tarsus Pharmaceuticals Inc. (NASDAQ: TARS), where he has overseen the commercial launch of XDEMVY for Demodex blepharitis. He previously held CFO positions at three companies that were acquired for more than $9 billion combined, including Global Blood Therapeutics, which Pfizer acquired for approximately $5.4 billion in December 2022.</p> <p>Waldman is founder and CEO of Veradermics Inc. (NYSE: MANE), http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html Tue, 02 Jun 2026 08:31:08 -0400 A.14610943 A.21388897 A.26756439 A.50113906 ACHV MANE O.00644671 O.13716952 O.45210133 O.48400419 O.48989253 O.53486143 TARS http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html <p>Achieve Life Sciences Inc. (NASDAQ: ACHV) appointed Jeffrey Farrow and Reid Waldman to its board of directors as the company prepares to resubmit its new drug application for cytisinicline, a smoking cessation treatment.</p> <p>Farrow serves as chief financial officer and chief strategy officer at Tarsus Pharmaceuticals Inc. (NASDAQ: TARS), where he has overseen the commercial launch of XDEMVY for Demodex blepharitis. He previously held CFO positions at three companies that were acquired for more than $9 billion combined, including Global Blood Therapeutics, which Pfizer acquired for approximately $5.4 billion in December 2022.</p> <p>Waldman is founder and CEO of Veradermics Inc. (NYSE: MANE), http://www.streetinsider.com/Board+Changes/Achieve+Life+Sciences+adds+two+board+members+ahead+of+drug+resubmission/26588160.html Tue, 02 Jun 2026 08:31:08 -0400 A.14610943 A.21388897 A.26756439 A.50113906 ACHV MANE O.00644671 O.13716952 O.45210133 O.48400419 O.48989253 O.53486143 TARS http://www.streetinsider.com/Press+Releases/Achieve+Life+Sciences+Appoints+Jeffrey+Farrow+and+Reid+Waldman%2C+MD+to+Board+of+Directors/26588134.html <p>SEATTLE and VANCOUVER, British Columbia, June 02, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (“Achieve” or the “Company”) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment for nicotine dependence, today announced that Jeffrey Farrow and Reid Waldman, MD have been appointed to its Board of Directors.</p> <p>“Jeffrey and Reid are exactly the kinds of operators you want around a board table when a company is preparing for its first launch,” said Lucian Iancovici, MD, incoming Chairman of the Board of Directors of Achieve. “Jeffrey has http://www.streetinsider.com/Press+Releases/Achieve+Life+Sciences+Appoints+Jeffrey+Farrow+and+Reid+Waldman%2C+MD+to+Board+of+Directors/26588134.html Tue, 02 Jun 2026 08:30:00 -0400 A.14610943 A.21388897 A.26756439 A.50113906 ACHV MANE O.00644671 O.13716952 O.45210133 O.48400419 O.48989253 O.53486143 TARS http://www.streetinsider.com/Press+Releases/Achieve+Life+Sciences+Appoints+Jeffrey+Farrow+and+Reid+Waldman%2C+MD+to+Board+of+Directors/26588134.html <p>SEATTLE and VANCOUVER, British Columbia, June 02, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (“Achieve” or the “Company”) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment for nicotine dependence, today announced that Jeffrey Farrow and Reid Waldman, MD have been appointed to its Board of Directors.</p> <p>“Jeffrey and Reid are exactly the kinds of operators you want around a board table when a company is preparing for its first launch,” said Lucian Iancovici, MD, incoming Chairman of the Board of Directors of Achieve. “Jeffrey has http://www.streetinsider.com/Press+Releases/Achieve+Life+Sciences+Appoints+Jeffrey+Farrow+and+Reid+Waldman%2C+MD+to+Board+of+Directors/26588134.html Tue, 02 Jun 2026 08:30:00 -0400 A.14610943 A.21388897 A.26756439 A.50113906 ACHV MANE O.00644671 O.13716952 O.45210133 O.48400419 O.48989253 O.53486143 TARS